| Financial Year |
March 31 2023 |
| Monetary Funds |
328,200,772.35 |
| Held-for-trading Financial Assets |
102,458,889.24 |
| Notes Receivable |
15,089,097.00 |
| Accounts Receivable |
86,100,267.74 |
| Advances to Suppliers |
3,523,843.99 |
| Other Receivables |
784,177.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
166,968,601.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,213,384.36 |
| Total Current Assets |
796,823,283.71 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
418,083,114.33 |
| Under-construction Projects |
27,758,677.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
68,765,933.37 |
| R&D expenses |
-- |
| Goodwill |
1,126,048.66 |
| Long-Term Deferred and Prepaid Expenses |
1,131,488.98 |
| Deferred Income Tax Assets |
4,504,174.51 |
| Other Non-Current Assets |
7,886,470.36 |
| Sub-Total of Non-Current Assets |
530,393,317.81 |
| Total Assets |
1,327,216,601.52 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
47,772,846.51 |
| Accounts Payable |
29,610,926.58 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,910,766.66 |
| Taxes Payable |
5,981,042.81 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
19,874,680.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
209,624.75 |
| Other Current Liabilities |
350,057.55 |
| Sub-Total of Current Liabilities |
115,402,834.25 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,905,209.79 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
13,193,864.98 |
| Total Liabilities |
128,596,699.23 |
| Paid-In Capital(Or Share Stock) |
135,222,509.00 |
| Capital Surplus |
211,226,093.78 |
| Surplus Reserve |
79,581,277.79 |
| LESS:Treasury Stock |
21,625,973.75 |
| Undistributed Profits |
738,977,910.22 |
| Minority Stockholder's Interest |
34,201,560.55 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,164,418,341.74 |
| Owner's Equity（Stockholder's Equity） |
1,198,619,902.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,327,216,601.52 |
